ADO (ASX) Ex ??? COO Tamara Mills

Originally posted by riverbrae ↑

Hi secondsight
OOPS

Chief Operations Officer

Company NameDE MOTU CORDIS

Dates EmployedFeb 2017 – Present

Employment Duration5 mos

LocationBrisbane, Australia
Chief Operations Officer at De Motu Cordis Pty. Ltd (DMC), a medtech startup commercially developing an advanced drug delivery system for critical care patients. The technology has the potential to significantly improve patient outcomes, reducing the long-term health costs of patients following cardiac arrest. Further products within the DMC portfolio leveraging the technology behind the critical care advanced drug delivery system include drug device combinations for improved treatment of hypoglycemia and anaphylaxis.

Co-Founder and CEO

Company NameGlucotek Inc

Dates EmployedMar 2017 – Present

Employment Duration4 mos

LocationBrisbane, Australia
Our mission is to make the management of gestational diabetes simple, non-invasive and easy, improving the lives of diabetic mothers and their babies.

Founder

Company NameFundamedtech

Dates EmployedMar 2015 – Present

Employment Duration2 yrs 4 mos

LocationMontreal, Canada Area
Fundamedtech is a niche medical technology start-up incubator specializing in complex medical device and digital health products.

While most health technology accelerators and incubators steer clear from ventures pursuing the development of complex medical technologies requiring pre-marketing authorization, this is our core focus.

Co Founder

Company NameSynaptecha

Dates EmployedJan 2016 – Present

Employment Duration1 yr 6 mos

LocationMontreal, Canada Area
Synaptecha is a medical technology startup developing smart beautifully designed medical devices to track and monitor patients with chronic illnesses

Founder

Company NameMSMx

Dates EmployedJan 2016 – Present

Employment Duration1 yr 6 mos

LocationMontreal, Canada Area
Today there is no simple effective method for diagnosing MS, there is no way of knowing upfront which treatment will be most effective for the patient and result in least side-effects, there is no quick effective means of monitoring response to treatment, treatment adherence and there is no means of being able to predict or prevent relapse, often resulting in hospital admission for treatment depending on severity. MSMx is developing a Diagnostic test with high sensitivity, specificity, strong negative and positive predictive value enabling early treatment of MS and prediction of treatment response in addition to a Wearable Integrated Digital health platform enabling real-time monitoring , trending and machine learning of personal and environmental factors correlated treatment, disease progression and relapse

Chief Operations Officer

Company NameAnteo Diagnostics

Dates EmployedJul 2016 – Feb 2017

Employment Duration7 mos

LocationAustralia
Led the operations and product commercialization for Anteo Diagnostics Limited (ASX: ADO), a global nanotechnology company developing and commercializing products for the life sciences, clinical diagnostics,medical device, energy, and bioseparations markets. The Anteo Group owns a patented nanochemistry surface engineering technology with high-value
commercial applications in protein binding and anti-body coupling, point of care devices, in-vivo medical devices, medical drug delivery, and batteries

Expand

Oops, must have tomatoes on my eyes. Or it is the heat, we have at the moment about 35 degree in Germany... ;-)
Thank's!

No.	Vol.	Price($)
4	384663	2.1¢

No.

Vol.

Price($)

384663

2.1¢

Price($)	Vol.	No.
2.2¢	616353	6

Price($)

Vol.

No.

2.2¢

616353

No.	Vol.	Price($)
4	384663	0.021
12	2157550	0.020
10	3040767	0.019
10	1652665	0.018
3	94160	0.017

No.

Vol.

Price($)

384663

0.021

2157550

0.020

3040767

0.019

1652665

0.018

94160

0.017

Price($)	Vol.	No.
0.022	616353	6
0.023	857853	5
0.024	1306228	3
0.025	214144	4
0.027	680612	2

Price($)

Vol.

No.

0.022

616353

0.023

857853

0.024

1306228

0.025

214144

0.027

680612

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $51.83M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.1¢	$3.414K	161.6K

Ex ??? COO Tamara Mills, page-8

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nimy to raise $1.21M to explore 'newsy' WA targets

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ex ??? COO Tamara Mills, page-8

Top Stories

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nimy to raise $1.21M to explore 'newsy' WA targets

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News